Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 613 | 2020 |
Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, KA Travisano, ... Cell 184 (1), 106-119. e14, 2021 | 333 | 2021 |
Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing J Carlson-Stevermer, AA Abdeen, L Kohlenberg, M Goedland, K Molugu, ... Nature communications 8 (1), 1711, 2017 | 155 | 2017 |
CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage J Sun, J Carlson-Stevermer, U Das, M Shen, M Delenclos, AM Snead, ... Nature communications 10 (1), 53, 2019 | 93 | 2019 |
A tortoise–hare pattern seen in adapting structured and unstructured populations suggests a rugged fitness landscape in bacteria JR Nahum, P Godfrey-Smith, BN Harding, JH Marcus, ... Proceedings of the National Academy of Sciences 112 (24), 7530-7535, 2015 | 88 | 2015 |
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 AJ Samelson, QD Tran, R Robinot, L Carrau, VV Rezelj, AM Kain, M Chen, ... Nature cell biology 24 (1), 24-34, 2022 | 64* | 2022 |
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication CG Williams, AS Jureka, JA Silvas, AM Nicolini, SA Chvatal, ... Cell reports 36 (5), 2021 | 54 | 2021 |
CRISPRoff enables spatio-temporal control of CRISPR editing J Carlson-Stevermer, R Kelso, A Kadina, S Joshi, N Rossi, J Walker, ... Nature communications 11 (1), 5041, 2020 | 37 | 2020 |
High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells B Steyer, J Carlson-Stevermer, N Angenent-Mari, A Khalil, T Harkness, ... Acta biomaterialia 34, 143-158, 2016 | 32 | 2016 |
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen A Mac Kain, G Maarifi, SM Aicher, N Arhel, A Baidaliuk, S Munier, ... Nature Communications 13 (1), 2442, 2022 | 30 | 2022 |
High-content analysis of CRISPR-Cas9 gene-edited human embryonic stem cells J Carlson-Stevermer, M Goedland, B Steyer, A Movaghar, M Lou, ... Stem cell reports 6 (1), 109-120, 2016 | 30 | 2016 |
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, K Travisano, ... BioRxiv, 2020 | 26 | 2020 |
Nanofibrous electrospun polymers for reprogramming human cells T Cordie, T Harkness, X Jing, J Carlson-Stevermer, HY Mi, LS Turng, ... Cellular and Molecular Bioengineering 7, 379-393, 2014 | 20 | 2014 |
Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2 IP Chen, JE Longbotham, S McMahon, RK Suryawanshi, MM Khalid, ... Cell reports 40 (3), 2022 | 18 | 2022 |
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases J Carlson-Stevermer, A Das, AA Abdeen, D Fiflis, BI Grindel, S Saxena, ... Nature communications 11 (1), 6277, 2020 | 10 | 2020 |
Increasing the precision of gene editing in vitro, ex vivo, and in vivo K Mueller, J Carlson-Stevermer, K Saha Current opinion in biomedical engineering 7, 83-90, 2018 | 10 | 2018 |
A CRISPR/Cas9 based strategy to manipulate the Alzheimer’s amyloid pathway J Sun, J Carlson-Stevermer, U Das, M Shen, M Delenclos, AM Snead, ... BioRxiv, 310193, 2018 | 9 | 2018 |
Genome editing in human pluripotent stem cells J Carlson-Stevermer, K Saha Stem Cell Banking: Concepts and Protocols, 165-174, 2017 | 7 | 2017 |
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets KM Haas, MJ McGregor, M Bouhaddou, BJ Polacco, EY Kim, TT Nguyen, ... Nature communications 14 (1), 6030, 2023 | 6 | 2023 |
Tracking and predicting human somatic cell reprogramming using nuclear characteristics K Molugu, T Harkness, J Carlson-Stevermer, R Prestil, NJ Piscopo, ... Biophysical Journal 118 (9), 2086-2102, 2020 | 6 | 2020 |